| Analysis at 2/19/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 3.98% | 24.55% | 42.25% | 50.78% |
| Analysis at 2/19/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 24.00% | 18.10% | 16.96% |
| Negative volatility | 13.48% | 10.54% | 10.12% |
| Sharpe | 0.74 | 0.49 | 0.45 |
| Sortino | 1.31 | 0.85 | 0.75 |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Candriam Eq. L Biotechnology C $ | 5.46% | 4.61% | 3.44% | 9.08% | 22.51% | 3.98% | |
| Equity Sector - Biotechnology | 16.35% | 15.35% | 0.35% | 6.70% | 8.38% | 4.40% | |